Global Microbiology Testing
Global Microbiology Testing

Microbiology Testing Comprehensive Study by Type (Instruments, Reagents), Application (Pharmaceutical, Clinical, Food Testing, Energy, Chemical and Material Manufacturing, Environment), Disease Area (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted diseases, Urinary Tract Infections, Periodontal Diseases, Other) Players and Region - Global Market Outlook to 2024

Microbiology Testing Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024 | CAGR: 6.7%  

Aug 2019 Edition 231 Pages 193 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Microbiology Testing Market Overview:
Microbial testing is an analytical techniques that applicable for determined the number of microorganisms in food, beverages, biological samples and environmental samples. Microbial testing market is expected to mark significant growth over forecasted period owing to increasing consumers spending on laboratory instruments such as incubators, gram strainers, bacterial colony counters & others and technological advancement. Microbial testing techniques exhibits with chemical, biological, biochemical and molecular methods. The major companies are adding more proven technologies systematically and strategically in Asia-Pacific countries as these countries are focused on fastest-growing verticals in the Pharmaceutical, Clinical, Food Testing, Energy, Chemical and Material Manufacturing sector. According to AMA, the Global Microbiology Testing market is expected to see growth rate of 6.7% and may see market size of USD4.97 Million by 2024.

Market Drivers
  • Rising Incidence of Infectious Diseases Boost the Market.
  • Growing Outbreaks of Epidemics.

Market Trend
  • Collaboration and Tie Up Of Leading Players
  • Substitutes Available For Microbiology Testing

Restraints
  • Limited Reimbursement Policies Hampers the Microbiology Testing Market.
  • Toxic Side Effects Associated within Microbiology Testing Market.

Opportunities
  • Proliferation of Real Time PCR and In Situ Hybridization Leads to Grow the Microbiology Testing Market.
  • Upsurge Demand Due to Funding and Investments from Public-Private Companies.

Challenges
  • Limitation due to Environmental Pollution Are Anticipated To Challenge The Market.


Competitive Landscape:

Some of the key players profiled in the report are 3M Company (United States), Accepta Ltd (United Kingdom), Agilent Technologies Inc. (United States), Aquagenx Llc (United States), Avantor Performance Materials Llc (United States), Biomrieux SA (France), Bio-Rad Laboratories Inc. (United States), Biotrack Bv (The Netherlands), Danaher Corporation (United States) and d. Additionally, following companies can also be profiled that are part of our coverage like Abbott Laboratories (United States) and Bio-Rad Laboratories, Inc. (United States). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Microbiology Testing market by 2024. Considering Market by Disease Area, the sub-segment i.e. Respiratory Diseases will boost the Microbiology Testing market.

Market Highlights:

In May 2018, BioMérieux launched an ENDOZYME II GO which is beneficial in providing innovative test for the detection of endotoxins in pharmaceutical microbiology control. It also control internal and standard dilutions for conventional endotoxin testing.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Microbiology Testing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Microbiology Testing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Microbiology Testing Manufacturers, Microbiology Testing Traders, End-Use Market Participants of Different Segments of Microbiology Testing, Government and Research Organizations, R&D Institutions and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Instruments
  • Reagents
By Application
  • Pharmaceutical
  • Clinical
  • Food Testing
  • Energy
  • Chemical and Material Manufacturing
  • Environment
By Disease Area
  • Respiratory Diseases
  • Bloodstream Infections
  • Gastrointestinal Diseases
  • Sexually Transmitted diseases
  • Urinary Tract Infections
  • Periodontal Diseases
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidence of Infectious Diseases Boost the Market.
      • 3.2.2. Growing Outbreaks of Epidemics.
    • 3.3. Market Challenges
      • 3.3.1. Limitation due to Environmental Pollution Are Anticipated To Challenge The Market.
    • 3.4. Market Trends
      • 3.4.1. Collaboration and Tie Up Of Leading Players
      • 3.4.2. Substitutes Available For Microbiology Testing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Microbiology Testing, by Type, Application, Disease Area and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Microbiology Testing (Value)
      • 5.2.1. Global Microbiology Testing by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Reagents
      • 5.2.2. Global Microbiology Testing by: Application (Value)
        • 5.2.2.1. Pharmaceutical
        • 5.2.2.2. Clinical
        • 5.2.2.3. Food Testing
        • 5.2.2.4. Energy
        • 5.2.2.5. Chemical and Material Manufacturing
        • 5.2.2.6. Environment
      • 5.2.3. Global Microbiology Testing by: Disease Area (Value)
        • 5.2.3.1. Respiratory Diseases
        • 5.2.3.2. Bloodstream Infections
        • 5.2.3.3. Gastrointestinal Diseases
        • 5.2.3.4. Sexually Transmitted diseases
        • 5.2.3.5. Urinary Tract Infections
        • 5.2.3.6. Periodontal Diseases
        • 5.2.3.7. Other
      • 5.2.4. Global Microbiology Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Microbiology Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Accepta Ltd (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agilent Technologies Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aquagenx Llc (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Avantor Performance Materials Llc (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Biomrieux SA (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bio-Rad Laboratories Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Biotrack Bv (The Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Danaher Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Microbiology Testing Sale, by Type, Application, Disease Area and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Microbiology Testing (Value)
      • 7.2.1. Global Microbiology Testing by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Reagents
      • 7.2.2. Global Microbiology Testing by: Application (Value)
        • 7.2.2.1. Pharmaceutical
        • 7.2.2.2. Clinical
        • 7.2.2.3. Food Testing
        • 7.2.2.4. Energy
        • 7.2.2.5. Chemical and Material Manufacturing
        • 7.2.2.6. Environment
      • 7.2.3. Global Microbiology Testing by: Disease Area (Value)
        • 7.2.3.1. Respiratory Diseases
        • 7.2.3.2. Bloodstream Infections
        • 7.2.3.3. Gastrointestinal Diseases
        • 7.2.3.4. Sexually Transmitted diseases
        • 7.2.3.5. Urinary Tract Infections
        • 7.2.3.6. Periodontal Diseases
        • 7.2.3.7. Other
      • 7.2.4. Global Microbiology Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Microbiology Testing: by Type(USD Million)
  • Table 2. Microbiology Testing Instruments , by Region USD Million (2013-2018)
  • Table 3. Microbiology Testing Reagents , by Region USD Million (2013-2018)
  • Table 4. Microbiology Testing: by Application(USD Million)
  • Table 5. Microbiology Testing Pharmaceutical , by Region USD Million (2013-2018)
  • Table 6. Microbiology Testing Clinical , by Region USD Million (2013-2018)
  • Table 7. Microbiology Testing Food Testing , by Region USD Million (2013-2018)
  • Table 8. Microbiology Testing Energy , by Region USD Million (2013-2018)
  • Table 9. Microbiology Testing Chemical and Material Manufacturing , by Region USD Million (2013-2018)
  • Table 10. Microbiology Testing Environment , by Region USD Million (2013-2018)
  • Table 11. Microbiology Testing: by Disease Area(USD Million)
  • Table 12. Microbiology Testing Respiratory Diseases , by Region USD Million (2013-2018)
  • Table 13. Microbiology Testing Bloodstream Infections , by Region USD Million (2013-2018)
  • Table 14. Microbiology Testing Gastrointestinal Diseases , by Region USD Million (2013-2018)
  • Table 15. Microbiology Testing Sexually Transmitted diseases , by Region USD Million (2013-2018)
  • Table 16. Microbiology Testing Urinary Tract Infections , by Region USD Million (2013-2018)
  • Table 17. Microbiology Testing Periodontal Diseases , by Region USD Million (2013-2018)
  • Table 18. Microbiology Testing Other , by Region USD Million (2013-2018)
  • Table 19. South America Microbiology Testing, by Country USD Million (2013-2018)
  • Table 20. South America Microbiology Testing, by Type USD Million (2013-2018)
  • Table 21. South America Microbiology Testing, by Application USD Million (2013-2018)
  • Table 22. South America Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 23. Brazil Microbiology Testing, by Type USD Million (2013-2018)
  • Table 24. Brazil Microbiology Testing, by Application USD Million (2013-2018)
  • Table 25. Brazil Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 26. Argentina Microbiology Testing, by Type USD Million (2013-2018)
  • Table 27. Argentina Microbiology Testing, by Application USD Million (2013-2018)
  • Table 28. Argentina Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 29. Rest of South America Microbiology Testing, by Type USD Million (2013-2018)
  • Table 30. Rest of South America Microbiology Testing, by Application USD Million (2013-2018)
  • Table 31. Rest of South America Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 32. Asia Pacific Microbiology Testing, by Country USD Million (2013-2018)
  • Table 33. Asia Pacific Microbiology Testing, by Type USD Million (2013-2018)
  • Table 34. Asia Pacific Microbiology Testing, by Application USD Million (2013-2018)
  • Table 35. Asia Pacific Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 36. China Microbiology Testing, by Type USD Million (2013-2018)
  • Table 37. China Microbiology Testing, by Application USD Million (2013-2018)
  • Table 38. China Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 39. Japan Microbiology Testing, by Type USD Million (2013-2018)
  • Table 40. Japan Microbiology Testing, by Application USD Million (2013-2018)
  • Table 41. Japan Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 42. India Microbiology Testing, by Type USD Million (2013-2018)
  • Table 43. India Microbiology Testing, by Application USD Million (2013-2018)
  • Table 44. India Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 45. South Korea Microbiology Testing, by Type USD Million (2013-2018)
  • Table 46. South Korea Microbiology Testing, by Application USD Million (2013-2018)
  • Table 47. South Korea Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 48. Taiwan Microbiology Testing, by Type USD Million (2013-2018)
  • Table 49. Taiwan Microbiology Testing, by Application USD Million (2013-2018)
  • Table 50. Taiwan Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 51. Australia Microbiology Testing, by Type USD Million (2013-2018)
  • Table 52. Australia Microbiology Testing, by Application USD Million (2013-2018)
  • Table 53. Australia Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 54. Rest of Asia-Pacific Microbiology Testing, by Type USD Million (2013-2018)
  • Table 55. Rest of Asia-Pacific Microbiology Testing, by Application USD Million (2013-2018)
  • Table 56. Rest of Asia-Pacific Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 57. Europe Microbiology Testing, by Country USD Million (2013-2018)
  • Table 58. Europe Microbiology Testing, by Type USD Million (2013-2018)
  • Table 59. Europe Microbiology Testing, by Application USD Million (2013-2018)
  • Table 60. Europe Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 61. Germany Microbiology Testing, by Type USD Million (2013-2018)
  • Table 62. Germany Microbiology Testing, by Application USD Million (2013-2018)
  • Table 63. Germany Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 64. France Microbiology Testing, by Type USD Million (2013-2018)
  • Table 65. France Microbiology Testing, by Application USD Million (2013-2018)
  • Table 66. France Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 67. Italy Microbiology Testing, by Type USD Million (2013-2018)
  • Table 68. Italy Microbiology Testing, by Application USD Million (2013-2018)
  • Table 69. Italy Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 70. United Kingdom Microbiology Testing, by Type USD Million (2013-2018)
  • Table 71. United Kingdom Microbiology Testing, by Application USD Million (2013-2018)
  • Table 72. United Kingdom Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 73. Netherlands Microbiology Testing, by Type USD Million (2013-2018)
  • Table 74. Netherlands Microbiology Testing, by Application USD Million (2013-2018)
  • Table 75. Netherlands Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 76. Rest of Europe Microbiology Testing, by Type USD Million (2013-2018)
  • Table 77. Rest of Europe Microbiology Testing, by Application USD Million (2013-2018)
  • Table 78. Rest of Europe Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 79. MEA Microbiology Testing, by Country USD Million (2013-2018)
  • Table 80. MEA Microbiology Testing, by Type USD Million (2013-2018)
  • Table 81. MEA Microbiology Testing, by Application USD Million (2013-2018)
  • Table 82. MEA Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 83. Middle East Microbiology Testing, by Type USD Million (2013-2018)
  • Table 84. Middle East Microbiology Testing, by Application USD Million (2013-2018)
  • Table 85. Middle East Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 86. Africa Microbiology Testing, by Type USD Million (2013-2018)
  • Table 87. Africa Microbiology Testing, by Application USD Million (2013-2018)
  • Table 88. Africa Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 89. North America Microbiology Testing, by Country USD Million (2013-2018)
  • Table 90. North America Microbiology Testing, by Type USD Million (2013-2018)
  • Table 91. North America Microbiology Testing, by Application USD Million (2013-2018)
  • Table 92. North America Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 93. United States Microbiology Testing, by Type USD Million (2013-2018)
  • Table 94. United States Microbiology Testing, by Application USD Million (2013-2018)
  • Table 95. United States Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 96. Canada Microbiology Testing, by Type USD Million (2013-2018)
  • Table 97. Canada Microbiology Testing, by Application USD Million (2013-2018)
  • Table 98. Canada Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 99. Mexico Microbiology Testing, by Type USD Million (2013-2018)
  • Table 100. Mexico Microbiology Testing, by Application USD Million (2013-2018)
  • Table 101. Mexico Microbiology Testing, by Disease Area USD Million (2013-2018)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Microbiology Testing: by Type(USD Million)
  • Table 112. Microbiology Testing Instruments , by Region USD Million (2019-2024)
  • Table 113. Microbiology Testing Reagents , by Region USD Million (2019-2024)
  • Table 114. Microbiology Testing: by Application(USD Million)
  • Table 115. Microbiology Testing Pharmaceutical , by Region USD Million (2019-2024)
  • Table 116. Microbiology Testing Clinical , by Region USD Million (2019-2024)
  • Table 117. Microbiology Testing Food Testing , by Region USD Million (2019-2024)
  • Table 118. Microbiology Testing Energy , by Region USD Million (2019-2024)
  • Table 119. Microbiology Testing Chemical and Material Manufacturing , by Region USD Million (2019-2024)
  • Table 120. Microbiology Testing Environment , by Region USD Million (2019-2024)
  • Table 121. Microbiology Testing: by Disease Area(USD Million)
  • Table 122. Microbiology Testing Respiratory Diseases , by Region USD Million (2019-2024)
  • Table 123. Microbiology Testing Bloodstream Infections , by Region USD Million (2019-2024)
  • Table 124. Microbiology Testing Gastrointestinal Diseases , by Region USD Million (2019-2024)
  • Table 125. Microbiology Testing Sexually Transmitted diseases , by Region USD Million (2019-2024)
  • Table 126. Microbiology Testing Urinary Tract Infections , by Region USD Million (2019-2024)
  • Table 127. Microbiology Testing Periodontal Diseases , by Region USD Million (2019-2024)
  • Table 128. Microbiology Testing Other , by Region USD Million (2019-2024)
  • Table 129. South America Microbiology Testing, by Country USD Million (2019-2024)
  • Table 130. South America Microbiology Testing, by Type USD Million (2019-2024)
  • Table 131. South America Microbiology Testing, by Application USD Million (2019-2024)
  • Table 132. South America Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 133. Brazil Microbiology Testing, by Type USD Million (2019-2024)
  • Table 134. Brazil Microbiology Testing, by Application USD Million (2019-2024)
  • Table 135. Brazil Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 136. Argentina Microbiology Testing, by Type USD Million (2019-2024)
  • Table 137. Argentina Microbiology Testing, by Application USD Million (2019-2024)
  • Table 138. Argentina Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 139. Rest of South America Microbiology Testing, by Type USD Million (2019-2024)
  • Table 140. Rest of South America Microbiology Testing, by Application USD Million (2019-2024)
  • Table 141. Rest of South America Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 142. Asia Pacific Microbiology Testing, by Country USD Million (2019-2024)
  • Table 143. Asia Pacific Microbiology Testing, by Type USD Million (2019-2024)
  • Table 144. Asia Pacific Microbiology Testing, by Application USD Million (2019-2024)
  • Table 145. Asia Pacific Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 146. China Microbiology Testing, by Type USD Million (2019-2024)
  • Table 147. China Microbiology Testing, by Application USD Million (2019-2024)
  • Table 148. China Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 149. Japan Microbiology Testing, by Type USD Million (2019-2024)
  • Table 150. Japan Microbiology Testing, by Application USD Million (2019-2024)
  • Table 151. Japan Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 152. India Microbiology Testing, by Type USD Million (2019-2024)
  • Table 153. India Microbiology Testing, by Application USD Million (2019-2024)
  • Table 154. India Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 155. South Korea Microbiology Testing, by Type USD Million (2019-2024)
  • Table 156. South Korea Microbiology Testing, by Application USD Million (2019-2024)
  • Table 157. South Korea Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 158. Taiwan Microbiology Testing, by Type USD Million (2019-2024)
  • Table 159. Taiwan Microbiology Testing, by Application USD Million (2019-2024)
  • Table 160. Taiwan Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 161. Australia Microbiology Testing, by Type USD Million (2019-2024)
  • Table 162. Australia Microbiology Testing, by Application USD Million (2019-2024)
  • Table 163. Australia Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 164. Rest of Asia-Pacific Microbiology Testing, by Type USD Million (2019-2024)
  • Table 165. Rest of Asia-Pacific Microbiology Testing, by Application USD Million (2019-2024)
  • Table 166. Rest of Asia-Pacific Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 167. Europe Microbiology Testing, by Country USD Million (2019-2024)
  • Table 168. Europe Microbiology Testing, by Type USD Million (2019-2024)
  • Table 169. Europe Microbiology Testing, by Application USD Million (2019-2024)
  • Table 170. Europe Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 171. Germany Microbiology Testing, by Type USD Million (2019-2024)
  • Table 172. Germany Microbiology Testing, by Application USD Million (2019-2024)
  • Table 173. Germany Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 174. France Microbiology Testing, by Type USD Million (2019-2024)
  • Table 175. France Microbiology Testing, by Application USD Million (2019-2024)
  • Table 176. France Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 177. Italy Microbiology Testing, by Type USD Million (2019-2024)
  • Table 178. Italy Microbiology Testing, by Application USD Million (2019-2024)
  • Table 179. Italy Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 180. United Kingdom Microbiology Testing, by Type USD Million (2019-2024)
  • Table 181. United Kingdom Microbiology Testing, by Application USD Million (2019-2024)
  • Table 182. United Kingdom Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 183. Netherlands Microbiology Testing, by Type USD Million (2019-2024)
  • Table 184. Netherlands Microbiology Testing, by Application USD Million (2019-2024)
  • Table 185. Netherlands Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 186. Rest of Europe Microbiology Testing, by Type USD Million (2019-2024)
  • Table 187. Rest of Europe Microbiology Testing, by Application USD Million (2019-2024)
  • Table 188. Rest of Europe Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 189. MEA Microbiology Testing, by Country USD Million (2019-2024)
  • Table 190. MEA Microbiology Testing, by Type USD Million (2019-2024)
  • Table 191. MEA Microbiology Testing, by Application USD Million (2019-2024)
  • Table 192. MEA Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 193. Middle East Microbiology Testing, by Type USD Million (2019-2024)
  • Table 194. Middle East Microbiology Testing, by Application USD Million (2019-2024)
  • Table 195. Middle East Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 196. Africa Microbiology Testing, by Type USD Million (2019-2024)
  • Table 197. Africa Microbiology Testing, by Application USD Million (2019-2024)
  • Table 198. Africa Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 199. North America Microbiology Testing, by Country USD Million (2019-2024)
  • Table 200. North America Microbiology Testing, by Type USD Million (2019-2024)
  • Table 201. North America Microbiology Testing, by Application USD Million (2019-2024)
  • Table 202. North America Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 203. United States Microbiology Testing, by Type USD Million (2019-2024)
  • Table 204. United States Microbiology Testing, by Application USD Million (2019-2024)
  • Table 205. United States Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 206. Canada Microbiology Testing, by Type USD Million (2019-2024)
  • Table 207. Canada Microbiology Testing, by Application USD Million (2019-2024)
  • Table 208. Canada Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 209. Mexico Microbiology Testing, by Type USD Million (2019-2024)
  • Table 210. Mexico Microbiology Testing, by Application USD Million (2019-2024)
  • Table 211. Mexico Microbiology Testing, by Disease Area USD Million (2019-2024)
  • Table 212. Research Programs/Design for This Report
  • Table 213. Key Data Information from Secondary Sources
  • Table 214. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Microbiology Testing: by Type USD Million (2013-2018)
  • Figure 5. Global Microbiology Testing: by Application USD Million (2013-2018)
  • Figure 6. Global Microbiology Testing: by Disease Area USD Million (2013-2018)
  • Figure 7. South America Microbiology Testing Share (%), by Country
  • Figure 8. Asia Pacific Microbiology Testing Share (%), by Country
  • Figure 9. Europe Microbiology Testing Share (%), by Country
  • Figure 10. MEA Microbiology Testing Share (%), by Country
  • Figure 11. North America Microbiology Testing Share (%), by Country
  • Figure 12. Global Microbiology Testing share by Players 2018 (%)
  • Figure 13. Global Microbiology Testing share by Players (Top 3) 2018(%)
  • Figure 14. Global Microbiology Testing share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. 3M Company (United States) Revenue, Net Income and Gross profit
  • Figure 17. 3M Company (United States) Revenue: by Geography 2018
  • Figure 18. Accepta Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 19. Accepta Ltd (United Kingdom) Revenue: by Geography 2018
  • Figure 20. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Agilent Technologies Inc. (United States) Revenue: by Geography 2018
  • Figure 22. Aquagenx Llc (United States) Revenue, Net Income and Gross profit
  • Figure 23. Aquagenx Llc (United States) Revenue: by Geography 2018
  • Figure 24. Avantor Performance Materials Llc (United States) Revenue, Net Income and Gross profit
  • Figure 25. Avantor Performance Materials Llc (United States) Revenue: by Geography 2018
  • Figure 26. Biomrieux SA (France) Revenue, Net Income and Gross profit
  • Figure 27. Biomrieux SA (France) Revenue: by Geography 2018
  • Figure 28. Bio-Rad Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Bio-Rad Laboratories Inc. (United States) Revenue: by Geography 2018
  • Figure 30. Biotrack Bv (The Netherlands) Revenue, Net Income and Gross profit
  • Figure 31. Biotrack Bv (The Netherlands) Revenue: by Geography 2018
  • Figure 32. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Danaher Corporation (United States) Revenue: by Geography 2018
  • Figure 34. Global Microbiology Testing: by Type USD Million (2019-2024)
  • Figure 35. Global Microbiology Testing: by Application USD Million (2019-2024)
  • Figure 36. Global Microbiology Testing: by Disease Area USD Million (2019-2024)
  • Figure 37. South America Microbiology Testing Share (%), by Country
  • Figure 38. Asia Pacific Microbiology Testing Share (%), by Country
  • Figure 39. Europe Microbiology Testing Share (%), by Country
  • Figure 40. MEA Microbiology Testing Share (%), by Country
  • Figure 41. North America Microbiology Testing Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • 3M Company (United States)
  • Accepta Ltd (United Kingdom)
  • Agilent Technologies Inc. (United States)
  • Aquagenx Llc (United States)
  • Avantor Performance Materials Llc (United States)
  • Biomrieux SA (France)
  • Bio-Rad Laboratories Inc. (United States)
  • Biotrack Bv (The Netherlands)
  • Danaher Corporation (United States)
  • d
Additional players considered in the study are as follows:
Abbott Laboratories (United States) , Bio-Rad Laboratories, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation